RS
Rajinder Singh
About Rajinder Singh
Data last updated:
Rajinder Singh is a Director at Delvion Pharmaceuticals Private Limited (since 2026), Director at Delphin Lifesciences Private Limited (since 2024) and Director at Gbm Force India Private Limited (since 2022). The companies operate in Pharma, Paper and Information Technology.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 28 Jan 2026 | 2026 | Active | ||
| Director | 27 Nov 2024 | 2024 | Active | ||
| Director | 23 Nov 2022 | 2022 | Active |
Board colleagues of Rajinder Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Humani Sharma | 10851552 | Delvion Pharmaceuticals Private Limited , Delphin Lifesciences Private Limited | Director |
| Lakhwinder Thakur | 10851551 | Delvion Pharmaceuticals Private Limited , Delphin Lifesciences Private Limited | Director |
| Surinder Kaur | 09801072 | Gbm Force India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajinder Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajinder Singh
Rajinder Singh currently holds 3 directorships: Delvion Pharmaceuticals Private Limited (Director, since 28 Jan 2026); Delphin Lifesciences Private Limited (Director, since 27 Nov 2024); Gbm Force India Private Limited (Director, since 23 Nov 2022).
Rajinder Singh was first appointed on 23 Nov 2022 as Director at Gbm Force India Private Limited. The most recent appointment on record is 28 Jan 2026 at Delvion Pharmaceuticals Private Limited.
The current boards of Rajinder Singh's companies include Humani Sharma (Delvion Pharmaceuticals Private Limited), Lakhwinder Thakur (Delvion Pharmaceuticals Private Limited), Surinder Kaur (Gbm Force India Private Limited).